Hadas Nicole R. (CIK 0001602396)

Latest company ownership

AKBA - Akebia Therapeutics, Inc.
Role: SVP, Chief Legal Officer
Shares held
651,243
Last filed at
May 14, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 13, 2024 May 14, 2024 Akebia Therapeutics, Inc. SVP, Chief Legal Officer Sell 48.8 -12,016 -1.81% ✓ $15.1K
Feb 29, 2024 Mar 1, 2024 Akebia Therapeutics, Inc. SVP, Chief Legal Officer Sell 50.0 -5,974 -0.89% ✗ $9.4K
Feb 27, 2024 Feb 29, 2024 Akebia Therapeutics, Inc. SVP, Chief Legal Officer Sell 48.8 -7,411 -1.10% ✓ $11.3K
May 24, 2023 May 25, 2023 Akebia Therapeutics, Inc. SVP, Chief Legal Officer Sell 95.0 +136,814 35.30% ✗ $77.3K
Mar 1, 2023 Mar 3, 2023 Akebia Therapeutics, Inc. SVP, Chief Legal Officer Sell 46.3 -13,034 -4.34% ✗ $11.4K
Feb 27, 2023 Mar 1, 2023 Akebia Therapeutics, Inc. SVP, Chief Legal Officer Sell 47.5 -6,677 -2.17% ✗ $5.4K
Feb 28, 2022 Mar 2, 2022 Akebia Therapeutics, Inc. SVP, Chief Legal Officer Sell 78.8 +28,938 1.97% ✗ $45.6K
Apr 1, 2021 Apr 1, 2021 Akebia Therapeutics, Inc. SVP, Chief Legal Officer Sell 52.5 -1,060 -0.39% ✗ $3.6K
Feb 26, 2021 Mar 2, 2021 Akebia Therapeutics, Inc. SVP, Chief Legal Officer Sell 91.3 +47,715 22.15% ✗ $48.5K
Feb 28, 2020 Mar 2, 2020 Akebia Therapeutics, Inc. SVP, Chief Legal Officer Sell 95.0 +54,950 34.82% ✗ $61.3K
Apr 11, 2019 Apr 12, 2019 Akebia Therapeutics, Inc. SVP, CLO & Secretary Sell 22.5 -11,929 -7.15% ✗ $91.9K
Dec 12, 2018 Dec 13, 2018 Akebia Therapeutics, Inc. SVP, General Counsel, Sec. Sell 22.5 -20,175 -16.61% ✗ $180.4K
Oct 2, 2017 Oct 4, 2017 Akebia Therapeutics, Inc. SVP, General Counsel, Sec. Sell 32.5 -7,803 -7.12% ✓ $155.2K
Jul 3, 2017 Jul 6, 2017 Akebia Therapeutics, Inc. SVP, General Counsel, Sec. Sell 26.3 -1,554 -1.40% ✗ $22.2K
Apr 3, 2017 Apr 4, 2017 Akebia Therapeutics, Inc. SVP, General Counsel, Sec. Sell 26.3 -1,556 -1.40% ✗ $14.3K
Jan 1, 2017 Jan 3, 2017 Akebia Therapeutics, Inc. SVP, General Counsel, Sec. Sell 26.3 -1,810 -2.14% ✗ $19K
Oct 1, 2016 Oct 4, 2016 Akebia Therapeutics, Inc. SVP, General Counsel, Sec. Sell 26.3 -1,556 -1.82% ✗ $13.9K
Jul 5, 2016 Jul 6, 2016 Akebia Therapeutics, Inc. SVP, General Counsel, Sec. Sell 26.3 -1,557 -1.79% ✗ $11.6K
Apr 4, 2016 Apr 5, 2016 Akebia Therapeutics, Inc. SVP, General Counsel, Sec. Sell 26.3 -1,556 -1.79% ✗ $14.6K
Jan 4, 2016 Jan 6, 2016 Akebia Therapeutics, Inc. SVP, General Counsel, Sec. Sell 26.3 -1,811 -2.73% ✗ $22.2K
Oct 2, 2015 Oct 5, 2015 Akebia Therapeutics, Inc. SVP, General Counsel, Sec. Sell 45.0 -1,484 -2.22% ✓ $12.9K
Jul 2, 2015 Jul 6, 2015 Akebia Therapeutics, Inc. SVP, General Counsel, Sec. Sell 45.0 -1,484 -2.18% ✓ $14.2K
Apr 2, 2015 Jul 2, 2015 Akebia Therapeutics, Inc. SVP, General Counsel, Sec. Sell 45.0 -1,483 -2.17% ✓ $13.5K
Jan 2, 2015 Jul 2, 2015 Akebia Therapeutics, Inc. SVP, General Counsel, Sec. Sell 45.0 -1,715 -2.44% ✓ $19.7K
Apr 1, 2015 Apr 6, 2015 Akebia Therapeutics, Inc. SVP, General Counsel, Sec. Sell 83.8 +3,056 4.18% ✓ $13.5K
Jan 1, 2015 Jan 5, 2015 Akebia Therapeutics, Inc. VP General Counsel & Secretary Sell 83.8 +2,824 4.02% ✓ $19.7K
Dec 2, 2014 Dec 3, 2014 Akebia Therapeutics, Inc. VP General Counsel & Secretary Sell 22.5 -5,910 -7.76% ✗ $67.6K
Mar 25, 2014 Mar 27, 2014 Akebia Therapeutics, Inc. Officer Buy 87.5 +3,500 4.82% ✗ $59.5K